The NIDDK, NIAAA and ODS are encouraging R21 applications involving secondary analysis of existing data sets relevant to diabetes and endocrine and metabolic diseases; digestive diseases and nutrition, including obesity and eating disorders; and kidney, urologic, and hematologic diseases. Read more.